Abstract
Background/Aims: Helicobacter pylori infection causes gastritis, peptic ulcers and gastric malignancies, and its eradication has been advocated by many groups. We determined the H. pylori carrier status and eradication rates of patients with chronic hepatitis C virus (HCV) infection. Methods: In total, 76 chronically HCV-infected patients were enrolled for comparison with 228 HCV-noninfected, age- and sex-matched controls. H. pylori infection was confirmed by H. pylori antibody and urea breath testing. Results: The H. pylori infection rate was significantly higher for HCV-infected patients (67 of 76, 88.2%) than for HCV-noninfected controls (158 of 228, 69.3%). Endoscopic findings showed that the rates of gastric ulcers and gastritis were significantly higher for the 67 HCV-infected patients with H. pylori infection (34.3% and 77.6%) than for the 158 HCV-noninfected controls with H. pylori infection (15.2% and 57.6%). Treatment to eradicate H. pylori had a significantly higher success rate for HCV-infected patients (61 of 67, 91.0%) than for HCV-noninfected controls (115 of 158, 72.8%). Conclusions: The markedly high H. pylori eradication rate observed in this study shows that eradication of H. pylori holds promise for the improvement of the long-term health condition of patients with chronic HCV infection.
| Original language | English |
|---|---|
| Pages (from-to) | 447-453 |
| Number of pages | 7 |
| Journal | Gut and Liver |
| Volume | 5 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - Dec 1 2011 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Hepatology
- Gastroenterology
Cite this
Treatment for eradication of Helicobacter pylori infection among chronic hepatitis C patients. / Furusyo, Norihiro; Walaa, Ahmed H.; Eiraku, Kunimitsu; Toyoda, Kazuhiro; Ogawa, Eiichi; Ikezaki, Hiroaki; Ihara, Takeshi; Hayashi, Takeo; Kainuma, Mosaburo; Masayuki, Murata; Hayashi, Jun.
In: Gut and Liver, Vol. 5, No. 4, 01.12.2011, p. 447-453.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Treatment for eradication of Helicobacter pylori infection among chronic hepatitis C patients
AU - Furusyo, Norihiro
AU - Walaa, Ahmed H.
AU - Eiraku, Kunimitsu
AU - Toyoda, Kazuhiro
AU - Ogawa, Eiichi
AU - Ikezaki, Hiroaki
AU - Ihara, Takeshi
AU - Hayashi, Takeo
AU - Kainuma, Mosaburo
AU - Masayuki, Murata
AU - Hayashi, Jun
PY - 2011/12/1
Y1 - 2011/12/1
N2 - Background/Aims: Helicobacter pylori infection causes gastritis, peptic ulcers and gastric malignancies, and its eradication has been advocated by many groups. We determined the H. pylori carrier status and eradication rates of patients with chronic hepatitis C virus (HCV) infection. Methods: In total, 76 chronically HCV-infected patients were enrolled for comparison with 228 HCV-noninfected, age- and sex-matched controls. H. pylori infection was confirmed by H. pylori antibody and urea breath testing. Results: The H. pylori infection rate was significantly higher for HCV-infected patients (67 of 76, 88.2%) than for HCV-noninfected controls (158 of 228, 69.3%). Endoscopic findings showed that the rates of gastric ulcers and gastritis were significantly higher for the 67 HCV-infected patients with H. pylori infection (34.3% and 77.6%) than for the 158 HCV-noninfected controls with H. pylori infection (15.2% and 57.6%). Treatment to eradicate H. pylori had a significantly higher success rate for HCV-infected patients (61 of 67, 91.0%) than for HCV-noninfected controls (115 of 158, 72.8%). Conclusions: The markedly high H. pylori eradication rate observed in this study shows that eradication of H. pylori holds promise for the improvement of the long-term health condition of patients with chronic HCV infection.
AB - Background/Aims: Helicobacter pylori infection causes gastritis, peptic ulcers and gastric malignancies, and its eradication has been advocated by many groups. We determined the H. pylori carrier status and eradication rates of patients with chronic hepatitis C virus (HCV) infection. Methods: In total, 76 chronically HCV-infected patients were enrolled for comparison with 228 HCV-noninfected, age- and sex-matched controls. H. pylori infection was confirmed by H. pylori antibody and urea breath testing. Results: The H. pylori infection rate was significantly higher for HCV-infected patients (67 of 76, 88.2%) than for HCV-noninfected controls (158 of 228, 69.3%). Endoscopic findings showed that the rates of gastric ulcers and gastritis were significantly higher for the 67 HCV-infected patients with H. pylori infection (34.3% and 77.6%) than for the 158 HCV-noninfected controls with H. pylori infection (15.2% and 57.6%). Treatment to eradicate H. pylori had a significantly higher success rate for HCV-infected patients (61 of 67, 91.0%) than for HCV-noninfected controls (115 of 158, 72.8%). Conclusions: The markedly high H. pylori eradication rate observed in this study shows that eradication of H. pylori holds promise for the improvement of the long-term health condition of patients with chronic HCV infection.
UR - http://www.scopus.com/inward/record.url?scp=81855176460&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=81855176460&partnerID=8YFLogxK
U2 - 10.5009/gnl.2011.5.4.447
DO - 10.5009/gnl.2011.5.4.447
M3 - Article
C2 - 22195242
AN - SCOPUS:81855176460
VL - 5
SP - 447
EP - 453
JO - Gut and Liver
JF - Gut and Liver
SN - 1976-2283
IS - 4
ER -